Literature DB >> 28410979

Post-migration follow-up of migrants identified to be at increased risk of developing tuberculosis at pre-migration screening: a systematic review and meta-analysis.

Isaac H Y Chan1, Nishta Kaushik1, Claudia C Dobler2.   

Abstract

BACKGROUND: Post-migration follow-up of migrants considered at increased risk of developing tuberculosis based on pre-migration screening abnormalities (high-risk migrants) is implemented in several low-incidence countries. We aimed to determine the rate of tuberculosis in this population to inform cross-border tuberculosis control policies.
METHODS: We searched MEDLINE and Embase (since inception to Jan 12, 2017) for studies evaluating post-migration follow-up of high-risk migrants. Outcomes evaluated were the number of tuberculosis cases occurring post-migration, expressed as the tuberculosis incidence per 100 000 person-years of follow-up, as cumulative incidence of tuberculosis per 100 000 persons, and the cumulative incidence of tuberculosis at the first post-migration follow-up visit. Random-effects models were used to summarise outcomes across studies.
FINDINGS: We identified 20 publications (describing 23 study cohorts) reporting the pre-migration screening outcomes of 8 355 030 migrants processed between Jan 1, 1981, and May 1, 2014, with 222 375 high-risk migrants identified. The pooled cumulative incidence of tuberculosis post-migration in our study population from 22 cohorts was 2794 per 100 000 persons (95% CI 2179-3409; I2=99%). The pooled cumulative incidence of tuberculosis at the first follow-up visit from ten cohorts was 3284 per 100 000 persons (95% CI 2173-4395; I2=99%). The pooled tuberculosis incidence from 15 cohorts was 1249 per 100 000 person-years of follow-up (95% CI 924-1574; I2=98%).
INTERPRETATION: The high rate of tuberculosis in high-risk migrants suggests that tuberculosis control measures in this population, including more sensitive pre-migration screening, preventive treatment of latent tuberculosis infection, or post-migration follow-up, are potentially effective cross-border tuberculosis control strategies in low-incidence countries. FUNDING: Australian National Health and Medical Research Council.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28410979     DOI: 10.1016/S1473-3099(17)30194-9

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN: 1473-3099            Impact factor:   25.071


  14 in total

1.  Cost-effectiveness of post-landing latent tuberculosis infection control strategies in new migrants to Canada.

Authors:  Jonathon R Campbell; James C Johnston; Mohsen Sadatsafavi; Victoria J Cook; R Kevin Elwood; Fawziah Marra
Journal:  PLoS One       Date:  2017-10-30       Impact factor: 3.240

2.  A cluster of multidrug-resistant Mycobacterium tuberculosis among patients arriving in Europe from the Horn of Africa: a molecular epidemiological study.

Authors:  Timothy M Walker; Matthias Merker; Astrid M Knoblauch; Peter Helbling; Otto D Schoch; Marieke J van der Werf; Katharina Kranzer; Lena Fiebig; Stefan Kröger; Walter Haas; Harald Hoffmann; Alexander Indra; Adrian Egli; Daniela M Cirillo; Jérôme Robert; Thomas R Rogers; Ramona Groenheit; Anne T Mengshoel; Vanessa Mathys; Marjo Haanperä; Dick van Soolingen; Stefan Niemann; Erik C Böttger; Peter M Keller
Journal:  Lancet Infect Dis       Date:  2018-01-08       Impact factor: 25.071

3.  Physicians' perspectives on communication and decision making in clinical encounters for treatment of latent tuberculosis infection.

Authors:  Claudia C Dobler; Sinthia Bosnic-Anticevich; Carol L Armour
Journal:  ERJ Open Res       Date:  2018-03-23

4.  What happens to migrant tuberculosis patients who are transferred out using a web-based system in China?

Authors:  Tao Li; Xin Du; Hemant Deepak Shewade; Kyaw Thu Soe; Hui Zhang
Journal:  PLoS One       Date:  2018-11-08       Impact factor: 3.240

5.  Cost-effectiveness of Latent Tuberculosis Infection Screening before Immigration to Low-Incidence Countries.

Authors:  Jonathon R Campbell; James C Johnston; Victoria J Cook; Mohsen Sadatsafavi; R Kevin Elwood; Fawziah Marra
Journal:  Emerg Infect Dis       Date:  2019-04       Impact factor: 6.883

6.  Is there a fundamental flaw in Canada's post-arrival immigrant surveillance system for tuberculosis?

Authors:  Richard Long; Leyla Asadi; Courtney Heffernan; James Barrie; Christopher Winter; Mary Lou Egedahl; Catherine Paulsen; Brenden Kunimoto; Dick Menzies
Journal:  PLoS One       Date:  2019-03-08       Impact factor: 3.240

7.  Targeting screening and treatment for latent tuberculosis infection towards asylum seekers from high-incidence countries - a model-based cost-effectiveness analysis.

Authors:  Florian M Marx; Barbara Hauer; Nicolas A Menzies; Walter Haas; Nita Perumal
Journal:  BMC Public Health       Date:  2021-11-26       Impact factor: 4.135

8.  Screening for Tuberculosis in Migrants: A Survey by the Global Tuberculosis Network.

Authors:  Lia D'Ambrosio; Rosella Centis; Claudia C Dobler; Simon Tiberi; Alberto Matteelli; Justin Denholm; Dominik Zenner; Seif Al-Abri; Fatma Alyaquobi; Marcos Abdo Arbex; Evgeny Belilovskiy; François-Xavier Blanc; Sergey Borisov; Anna Cristina C Carvalho; Jeremiah Muhwa Chakaya; Nicola Cocco; Luigi Ruffo Codecasa; Margareth Pretti Dalcolmo; Keertan Dheda; Anh Tuan Dinh-Xuan; Susanna R Esposito; José-María García-García; Yang Li; Selene Manga; Valentina Marchese; Marcela Muñoz Torrico; Emanuele Pontali; Adrián Rendon; Denise Rossato Silva; Rupak Singla; Ivan Solovic; Giovanni Sotgiu; Martin van den Boom; Nguyen Viet Nhung; Jean-Pierre Zellweger; Giovanni Battista Migliori
Journal:  Antibiotics (Basel)       Date:  2021-11-05

9.  Practical challenges and solutions to TB control in a lower-middle-income country: experiences from Mongolia.

Authors:  Claudia C Dobler; Ochirbat Batbayar; Cameron M Wright
Journal:  Breathe (Sheff)       Date:  2018-09

10.  Post-migration follow-up programme for migrants at increased risk of developing tuberculosis: a cohort study.

Authors:  Nishta Kaushik; Chris Lowbridge; Gabriella Scandurra; Claudia C Dobler
Journal:  ERJ Open Res       Date:  2018-07-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.